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Background: The Glomerular Filtration Rate (GFR) is the best indicator of renal function. 
Serum cystatin C has been introduced as an endogenous marker of GFR. However, there are 
conflicting reports regarding its use in pregnancy and pre-eclampsia. We aimed to assess the 
GFR changes in pre-eclampsia, evaluate the use of serum cystatin C as an indicator of GFR 
and to identify other biomarkers for detection of pre-eclampsia. Methods: This was a case-
control study, conducted between December 2008 and December 2010, in Omdurman 
Maternity Hospital. The study group was 72 pre-eclamptic cases compared to 96 normal 
pregnant and 63 non-pregnant Sudanese women. Clinical and laboratory parameters including 
blood samples and 24-hour urine output were recorded. Total blood count, serum liver 
enzymes, renal function tests and serum cystatin C. Creatinine clearance and GFR were 
calculated. Results: Serum cystatin C level in the pre-eclamptic cases was significantly higher 
than the normal pregnant (P=0.000) and the non–pregnant participants (P=0.0001). Mean GFR 
of the pre-eclamptic cases was significantly lower than that of normal pregnant (P=0.0001) and 
the non-pregnant (P=0.0001). GFR of pre-eclamptic cases did not correlate with serum cystatin 
C nor with serum uric acid, but was negatively correlated with serum creatinine (r=-0.31, 
P=0.02). Serum cystatin C correlated with serum albumin (r=-0.41, P=0.0001), serum aspartate 
aminotransferase (r=0.26, P=0.03) and serum uric acid (r=0.60,P=0.0001) in the pre-eclamptic 
group. The diagnostic accuracy tests showed that serum cystatin C was a good detector of pre-
eclampsia but not a reliable marker of GFR changes in pre-eclampsia. Conclusions: In pre-
eclampsia, serum cystatin C level was significantly higher than in normal pregnancy. Serum 
cystatin C was superior to serum uric acid and serum creatinine in detection of pre-eclampsia 
but not a reliable indicator of GFR. Serum albumin and serum aspartate transferase can be used 





The Glomerular Filtration Rate (GFR) decreases early, 
in kidney disease, before the onset of any symptoms of 
renal failure (Manjunathet.al., 2001). The decrease 
corresponds with the extent of damage caused by the 
kidney disease (Schainuck et.al., 1970; Striker et.al., 
1970). 
Normal reproductive and renal functions are required 
during pregnancy (Phyllis, 1990). Physiological 
changes occur normally during pregnancy and marked 
renal and ‘haemodynamic’ changes are obvious by the 
end of the first trimester. GFR and effective renal 
plasma flow (ERPF) increase by 50% (Frederiksen, 
2001; Baylis, 1987). In the final weeks of pregnancy, 
GFR usually declines to nearly non-pregnant values  
(Linheimer and Katz, 2000). 
Pre-eclampsia affects about five percent of all 
pregnancies (Siddiquiet.al., 2010), (which is a multi-
system disorder, occurring in the second half of 
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pregnancy and is accompanied with increased rates of 
fetal and maternal morbidity and mortality (Redman 
and Sargent, 2005; Fisher et.al., 1981). 
The syndrome is characterized by vasospasm, haemo-
concentration and ischaemic changes in the placenta, 
kidney, liver and brain (James et.al., 2003). Both renal 
plasma flow and GFR decrease in pre-eclampsia, 
although absolute values may remain above the non-
pregnant range (Moran et. al. 2003). Altered renal 
function is a basic element of the pathophysiological 
process of pre-eclampsia (Hladunewichet.al., 2007). 
Serum cystatin concentration is exclusively glomerular 
rate dependent and therefore its serum assay shows a 
more precise analysis of the renal function than serum 
creatinine Cystatin C gives a better view for mild renal 
damage and is a more sensitive marker of changes in 
GFR than creatinine (Amgadet.al., 2004). It was 
diagnostically superior to serum creatinine (Villa et.al., 
2005). Small increases of cystatin C was associated 
with increased mortality in intensive care unit patients 
independent of acute kidney injury by  acute kidney 
injury network  criteria (Kwon et.al., 2011). Serum 
cystatin C is also used as a new biomarker for early 
detection of renal injury associated with metabolic 
syndrome and cardiovascular risk(Sheen and Sheu, 
2011). 
Measurement of the three angiogenic molecules: 
soluble endogolin, placental growth factor and soluble 
FMS-Like Tyrosine Kinase was more strongly 
predictive of pre-clampsiathan the individual 
biomarkers (Levine et.al., 2006). Renal biopsies were 
performed and showed that serum cystatin C reflected 
glomerular endotheliosis in normal, hypertensive and 
pre-eclamptic pregnancies. They reported a significant 
correlation of serum cystatin C with glomerular volume 
(Strevenset.al., 2001). On the other hand, trophoblast 
invasion, in pregnancy, is controlled by proteases and 
their inhibitors (e.g cystatin C), so serum level of 
cystatin C is increased in late pregnancy 
(Christenssonet.al.,2003). In pre-eclampsia, placental 
expression and secretion of cystatin C could contribute 
to the elevated maternal plasma levels of cystatin 
C(Karl and Mansson, 2007). 
The number of Sudanese women who develop pre-
eclampsia and subsequently eclampsia is high and a 
genuine concern. Maternal deaths in Sudan were 957 
out of 457491 live births (LB) in 2010. Direct maternal 
deaths were 567/957(63.1%).The main causes were 
haemorrhage, eclampsia and sepsis in thatorder. 
Maternal mortality in association with pre-eclampsia in 
the years 2010 and 2011 were 14.9% and 11.3% 
respectively(Umbeliet.al., 2012). 
We aimed to assess GFR changes in pre-eclampsia, 
evaluate the use of serum cystatin C as an indicator of 





This was a cross-sectional, case-control and hospital-
based study performed during a two-year period from 
December 2008 to December 2010; in Omdurman 
Maternity Hospital, Sudan. Omdurman Maternity 
Hospital has a large catchment area and covers a large 
population of the National Capital. Two obstetricians 
were responsible for the recruitment of the study 
participants. The pre-eclamptic cases were pregnant 
women with blood pressure ≥ 140/90 mmHg and 
proteinuria and in their second half of pregnancy (20 
weeks of pregnancy and onwards) (ACOG,2002).The 
control pregnant women had normal blood pressure and 
no proteinuria and were in their second half of 
pregnancy. Normal pregnant and pre-eclamptic cases 
were selected randomly (1in3) in the antenatal care 
clinics and those who fulfilled the requirements were 
included. The pre-eclamptic participants included 
newly discovered and already diagnosed and followed-
up cases in their recent pregnancies.  The non-pregnant 
group was selected from the midwives and nurses of 
Omdurman Maternity Hospital, the female officers and 
trainees of Sudan Police Headquarters and the female 
students of Ribat University. All selected participants 
were informed about the study; and their written 
consent was taken in advance.   
The inclusion criteria required that all the pregnant 
participants and non-pregnant control group to have no 
history of diabetes mellitus, essential hypertension, 
renal disease or any other chronic disease. The 
exclusion criteria included subjects with multiple 
pregnancies and/or have any obstetrical abnormality. 
The participants who showed abnormal thyroid 
function tests were also excluded (a post-test exclusion 
criterion)(Niet.al., 1998). 
Data Collection 
All participants were interviewed according to a pre-
constructed questionnaire.  The assigned obstetricians 
(authors 3 and 4) performed complete medical and 
obstetrical examination. All pregnancies were dated by 
the obstetrical examination and followed by 
ultrasonography measurement. The selected pre-
eclamptic and normal pregnant groups had follow–up 
cards to monitor their pregnancies. They were admitted 
in the morning into the antenatal wards after their 
consent was taken. The blood samples were collected 
and the blood was centrifuged and the sera collected. 
Each subject emptied her bladder completely after 
cleaning the vulva and the mid-stream urine was taken 
and tested for proteins. The time was recorded. The 
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subjects were watched closely by nurses trained by the 
first author. They accompanied the subjects to toilets 
every time from that time and onwards whenever was 
required. The urine passed out was collected in the 24-
hours in a urine container in which 5 ml of 
hydrochloric acid was added in advance. 
The subjects were given meals with free intake of fluids 
and told to lie on their lateral and not the supine 
position to avoid pressure over the ureters and bladder 
by the pregnant uterus. Another urine sample was taken 
from the subject before discharge and urine analysis for 
proteins was performed again. The 24-hour urine 
volumes were measured and the amounts recorded in 
the same laboratory. A urine sample for each subject 
was kept for urine analysis. All the urine and serum 
samples were kept at -80oc.The liver enzymes, serum 
creatinine and urine creatinine, serum cystatin C, serum 
albumin, uric acid and urine proteins were measured. 
Creatinine clearance was used to estimate GFR.Serum 
creatinine, urine creatinine and the 24-hour urine output 
were used to calculate the creatinine clearance. GFR 
was calculated in ml/min/m2 in accordance with John 
Hopkins’ method and using creatinine clearance 
corrected with body surface area (ABX, 2010). 
 
Techniques of Biochemical Analysis  
Atomic absorption spectrophotometer (Siemens Advia 
2400 Chemistry System) was used to analyze Aspartate 
Aminotransferase, Alanine Aminotransferase, serum 
cystatin C, serum and urine creatinine, blood urea and 
uric acid. DAKO Cystatin C PET kit for quantitative 
determination of Cystatin C concentration in human 
serum was used. Siemens Advia Centaur XP 
Immunoassay System was used to analyze Thyroid 
Stimulating Hormone and Free Thyroxine. 
 The urine was analyzed for proteins using the dipstick , 
Traces of proteins was equivalent to 5-20 mg/dl; 1+ 
equivalent to 30 mg/dl; 2+ equivalent to 100 mg/dl; 3+ 
equivalent to 300 mg/dl and 4+ equivalent to >300 
mg/dl.   
 
Ethical Consideration 
Ethical approval was given by the Research Committee 
(Faculty of Medicine,U of K). Permission was given 
from Omdurman Maternity Hospital to conduct the 
study. A written consent of all the study subjects was 
given prior to entry in the study. There is no conflict of 
interest to any of the authors.   
Statistical Analysis 
The sample size calculation was done from the 
statistical records of Omdurman Maternity Hospital. 
The samples selection was done by a systematic 
random selection.  
The data were presented as Means + S.E. of the means 
and confidence intervals. Correlation between 
quantitative data was determined using Spearman’s 
test. P< 0.05 was considered statistically significant. 
The diagnostic value of serum cystatin C, serum 
creatinine and serum uric acid for identifying renal 
dysfunction was evaluated using sensitivity, specificity, 
positive and negative likelihood ratios and/or receiving 
operating characteristic curve analysis (ROC) (Bewick 
et. al., 2004). The SPSS R 9.0 (SPSS, Inv., Chicago, IL, 
USA) program Version 20 was used in data analysis. 
Mann Whitney and Kruskal Wallis tests were used for 




The pre-eclamptic cases were 72, the normal pregnant 
subjects 93 and the non- pregnant subjects were 63. 
Mean Body Mass Index (BMI – kg/m2) of the pre-
eclamptic (29.5±1.0 range 27.75-31.21) was 
significantly higher than the non-pregnant 
(23.9±0.6range - 22.59-24.98) (P=0.0001) and the 
normal pregnant (25.6±0.5 range - 24.69-26.63) 
(P=0.0001). 
Mean systemic blood pressure of the pre-eclamptic 
(142.7 mmHg±2.0 range- 138.31-145.91) was 
significantly higher from the non-pregnant (115.00 
mmHg±1.3 range- 112.30-117.32) (P=0.0001) and the 
normal pregnant (114.00±1.2 mmHg range- 111.76-
116.51) (P=0.0001). 
Mean diastolic blood pressure of the pre-eclamptic 
(96.9 mmHg±1.2 range  94.94-99.09) was significantly 
higher than the non-pregnant (78.6 mmHg±0.7 range  
77.13-79.79) (P=0.0001) and the normal pregnant (77.2 
mmHg±1.01 range 75.28-79.29) 
Mean serum albumin of the pre-eclamptic (34.60g/L ± 
0.87 range 32.85-36.34) was significantly lower from 
the non-pregnant (45.83g/L ± 0.29 range 45.25-46.41) 
(P=0.0001) and the normal pregnant (35.63g/L ± 0.34 
range  34.95-36.31) (P=0.0001). 
Mean serum alanine transferase (ALT) of the pre-
eclamptic (12.1U/L ± 2.27 range 7.49-16.53) was 
significantly higher from the non-pregnant (10.89U/L ±  
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Fig.1: Means and Confidence Intervals for GFR (ml/min/1.73m2), Serum Creatinine (µmol/L), Serum Cystatin C (mg/L) and 
Serum Uric Acid (mmol/L) in Non-pregnant   , Pregnant and Pre-eclamptic Subjects 
 
.6 range 9.66-12.10) (P=0.002) and the normal 
pregnant (8.61U/L ± 0.29 range  8.03-9.19) (P=0.001). 
Mean serum aspartate transferase (AST) of the pre-
eclamptic (22.94U/L ± 3.71 range15.55-30.33) was not 
significantly different from the non-pregnant (20.52U/L 
± 1.18 range 18.16-22.88) but significantly different 
from the normal pregnant (16.00U/L ± 0.52 range 
14.96-17.03) (P=0.02). 
Mean serum cystatin C of the pre-eclamptic 
(1.3mg/L±0.0 range 1.23-1.38) was significantly higher 
than the non-pregnant (0.8mg/L±0.0 range 0.77-0.83) 
(P=0.0001) and the normal pregnant (1.0mg/L±0.0 
range 0.94-1.05) (P=0.0001). (Fig.1C) 
Mean serum uric acid of the pre-eclamptic 
(0.342mmol/L±0.01 range 0.317-0.367) was 
significantly higher from the non-pregnant 
(0.247mmol/L±0.01 range 0.232-0.262) (P=0.0001) 
and the normal pregnant (0.250mmol/L ± 0.01 range 
0.234-0.266) (P=0.0001). (Fig.1D) 
Mean serum creatinine of the pre-eclamptic 
(68.6µmol/L ± 1.8 range 67.39-74.82) was significantly 
different from the non-pregnant (75.5µmol/L ± 0.8  
 
range 73.73-77.03) (P=0.0001) and the normal 
pregnant (62.21 µmol/L ± 0.91 range 60.39-63.95) 
(P=0.0001). (Fig.1B) 
Mean urine creatinine of the pre-eclamptic (5.6mmol/L 
± 0.6 range 4.47-6.78) was significantly lower from the 
non-pregnant (11.9mmol/L ± 1.0 range 9.90-13.70) 
(P=0.0001) and the normal pregnant (6.8mmol/L ± 0.3 
range 6.08-7.44) (P=0.0001) 
All pre-eclamptic cases had positive urine protein as 
follows: 31.6% had 1+ protein, 31.6% had 2+ proteins, 
30.3% had 3+ proteins, 1.3% had 4+ proteins and 5.3% 
had traces protein. The non-pregnant subjects, 80% of 
them, had negative urine protein; while of the normal 
pregnant 86.9% had negative urine protein. Mean urine 
protein of the pre-eclamptic (2.0±0.1) was significantly  
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Fig.3: ROC to Compare Serum Cystatin C, Serum Creatinine 
and Serum Uric Acid in Pre-eclamptic Cases for Detection of 
Pre-eclampsia. 
 
higher from the non-pregnant (0.3±0.1) (P=0.0001) and 
the normal pregnant (0.3±0.1) (P=0.0001). 
Mean GFR of the pre-eclamptic 
(68.6ml/min.1.73m2±3.3 range 62.06-75.14) was 
statistically significantly less than the non-pregnant 
(87.0ml/min/1.73m2±3.4 range 80.41-93.59) 
(P=0.0001) and the normal pregnant 
(89.0ml/min/1.73m2±2.8 range 83.57-94.43) (P = 
0.0001). (Fig.1A) 
 
The sensitivity at a cut-off value of serum cystatin C of 
1.0 mg/L was 0.8(Fig.2A) and the specificity at a cut-
off of 1.5 mg/L was 0.95 for pre-eclampsia. (Fig. 2B) 
LR+ for serum cystatin C was found to be reasonably 
high in the range shown (1.25-1.75mg/L) (Fig. 2C). 
DOR was reasonably high in range shown for serum 
cystatin C (0.75-1.75) (Fig.2D). 
The diagnostic accuracy of serum cystatin C using 
ROC-plot was found to be better than serum creatinine 
and serum uric acid for detection of pre-eclampsia. 
(Fig.3)  
A value for GFR of 40 ml/min/1.73m2 or less was 
considered critically low which was observed in 6 
cases. (Fig. 4). 
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Fig.   4: ROC-40 Plot the Diagnostic Value of Serum 
Cystatin C, Serum Creatinine and Serum Uric Acid at Cut-
off GFR 40 (ml/min/1.73m2) in pre-eclampsia 
 
 
GFR of the normal pregnant group correlated 
negatively and significantly with serum cystatin C (r=-
0.26, P=0.02) and with serum uric acid (r=-0.35, P= 
0.001). GFR of the pre-eclamptic group did not 
correlate neither with serum uric acid (r= -0.19, P= 
0.171) nor with serum cystatin C (r=-0.18, P= 0.192). 
In the pre-eclamptic group, serum cystatin C correlated 
positively and significantly with serum uric acid 
(r=0.60, P=0.000) but not with serum creatinine 
(r=0.04). Serum cystatin C correlated positively and 
significantly with serum aspartate aminotransferase (r= 
0.25, P=0.01) in the normal pregnant group. Serum 
cystatin C correlated negatively and significantly with 
serum albumin (r= -0.41, P=0.0001), and positively and 
significantly with serum aspartate aminotransferase (r= 
0.26, P=0.03) and serum uric acid (r= 0.60, P=0.0001) 
in the pre-eclamptic cases. 
 
Discussion 
In this study, mean GFR of pre-eclamptic cases was 
statistically significantly lower than that of non-
pregnant and of normal pregnant women. This is due to 
the marked renal impairment and glomerular 
endotheliosis which accompanies pre-eclampsia 
(Strevenset.al., 2001). Unchecked steep decline in GFR 
in pre-eclamptic patients may result in renal failure. A 
similar significant decline in GFR of  
pre-eclamptic cases was reported compared to the 
normal pregnant control group (Lafayette et. al., 1998). 
In this study, serum cystatin C was measured in the 
three study groups. The results showed that it increased 
significantly in the normal pregnant women compared 
to the control group. A similar result was reported by 
Strevens et. al. who measured serum cystatin C in 
normal pregnant and non-pregnant subjects. They 
found an increased level of cystatin C in the normal 
pregnant subjects (Strevens et.al., 2002).  
In further research based on renal biopsies in 
pregnancy, they reported that there was a degree of 
glomerular endotheliosis in normal pregnancy. This 
may lead to a decrease in the filtration of serum 
cystatin C and thus increase its serum level though the 




Fig. 5: ROC-50 Plot the Diagnostic Value of Serum Cystatin 
C, Serum Creatinine and Serum Uric Acid at Cut-off GFR 50 
(ml/min/1.73m2) in Pre-eclamptic Cases. 
 
 
This finding is further supported by Malyszkoet. al.. 
They performed a study to assess the use of 
Netrophilgelatinase associated lipocalin and cystatin C 
to reflect kidney function in pregnancy. NGAL 
correlated with cystatin C. They explained the steady 
rise of cystatin C in pregnancy by the fact that cysteine 
proteases are important in pregnancy for embedding 
and trophoblast invasion of the placenta. Cystatin C is 
synthesized by the embedded placenta and secreted by 
trophoblast cells into the maternal and fetal circulation 
(Malyszko, 2010). An increase of serum cystatin C in 
pregnancy was reported (Bramham et.al.,2010). In the 
current study, the pre-eclamptic cases mean serum 
cystatin C increased significantly when compared to 
non-pregnant and normal pregnant subjects. The mean 
serum cystatin C values were different in the three 
groups with a persistent rise and peak in pre-eclampsia.  
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Fig.   6: ROC-60 Plot the Diagnostic Value of Serum 
Cystatin C, Serum Creatinine and Serum Uric Acid at Cut-
off GFR 60 (ml/min/1.73m2) in Pre-eclamptic Cases 
 
 
The pathological changes of marked glomerular 
endotheliosis, in pre-eclampsia, may have led to 
reduced GFR and higher serum cystatin level in the 
pre-eclamptic group (Strevenset.al., 2001). 
Malyszkoet. al also stated that the imbalance of 
trophoblast cathepsin/cystatin C levels, which occurs in 
pre-eclampsia, may even increase more the serum 
cystatin C level. They explained that high serum levels 
of cystatin C, in pre-eclampsia, were not only due to 
impaired renal function but also to its increased 
secretion by the malformed placenta (Malyszkoet.al., 
2010). 
 The diagnostic accuracy tests using ROC-plot for 
serum cystatin C at different cut-off values showed it to 
be a reliable indicator for detection of pre-eclampsia. It 
also showed the superiority of serum cystatin C on 
serum creatinine. Thus, serum cystatin C was found to 
be better than serum creatinine and serum uric acid for 
detection of pre-eclampsia.  
In this study, in the pre-eclamptic cases, there was no 
correlation between the GFR and serum cystatin C. 
Serum albumin level decreased significantly in 
pregnancy, due to the haemodilution of pregnancy. It 
decreased even more in pre-eclampsia. 
Serum cystatin C correlated significantly with serum 
albumin, serum AST and serum uric acid in the pre-
eclamptic cases. Serum cystatin C did not correlate 
significantly with the blood pressure and urine albumin 
in the pre-eclamptic cases. 
The combination of multiple serum markers increased 
serum cystatin C, decreased serum albumin and 
increased serum AST enables the detection ALT and 
AST are strong prognostic indicators of pre-eclampsia. 
Increase in their levels may indicate deterioration of the 
condition (Redman et al, 2005). In this study, both ALT 
and AST increased in the pre-eclamptic cases when 
compared to normal pregnant women. 
 
Conclusions 
Serum cystatin C increased in normal pregnancy and 
more in pre-eclampsia. It was found to be diagnostic of 
pre-eclampsia using the diagnostic accuracy tests. 
Increased serum cystatin C, in the pre-eclamptic cases, 
correlated significantly with decreased serum albumin 
and increased serum aspartate aminotransferase. A 
combination of the three tests can be a better detection 
of pre-eclampsia. This finding also emphasizes 
compromised liver function in pre-eclampsia. Serum 
cystatin C had no correlation with GFR in pre-
eclampsia. Thus, it cannot be used to reflect the GFR in 
pre-eclampsia.The limitations of the use of serum 
cystatin C, serum creatinine and serum uric acid for 
GFR changes in pre-eclampsia were confirmed. Serum 
cystatin C, in the pre-eclamptic cases did not correlate 
with the raised blood pressure and proteinuria.  
 
Abbreviations: GFR, glomerular filtration rate; ERPF, 
effective renal plasma flow; ROC, receiving operating curve; 
BMI, body mass index; CI, confidence interval; ALT, 
alanine aminotransferase; AST, aspartate aminotransferase; 
DOR, diagnostic odd ratio; L+R, likelihood ratio; SPSS, 
statistical package for the social sciences. 
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